Oncogenic mutations in KRAS are found most frequently in codons 12 and 13 of exon 2 and occur in ∼30–45% of CRC tumours (Lievre et al, 2006; Benvenuti et al, 2007; Di Fiore et al, 2007). Here, KRAS is linked to neoplasm.